Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
Clinical trial NCT06577961 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06577961
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-31
- Primary completion
- 2027-08-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.